Furthermore, CTLA4+ T cells secrete S100A4, which induces a stem-like phenotype in TNBC cells (45), while CD44 has been recognized as a stem cell marker in BC that binds multiple ECM components, notably hyaluronic acid (HA), modifying tumor behavior through co-receptor interactions (46). This evidence concerns the gene CD44 and breast cancer.